Small-molecule CBLB inhibitor abolishes EGFR ubiquitination, reduces receptor endocytosis, and diminishes cell motility signaling

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
Affiliations:
2
Authors:
4
Institutions Authors Share
University of Pittsburgh (Pitt), United States of America (USA)
2.000000
0.50
Nurix Therapeutics, United States of America (USA)
2.000000
0.50